Skip to search.
 TSX Up 0.15% TSX Ventures Down 0.75%

XOMA Corporation (XOMA)

-NasdaqGM
0.78 Up 0.01(0.84%) 4:00PM EDT
|After Hours : 0.78 Down 0.00 (0.03%) 4:58PM EDT
Add to Portfolio
Prev Close:0.77
Open:0.74
Bid:0.72 x 1000
Ask:0.81 x 500
1y Target Est:4.50
Beta:3.4
Next Earnings Date: 6-Aug-15XOMA Earnings announcement
Day's Range:0.73 - 0.80
52wk Range:0.73 - 5.95
Volume:2,798,425
Avg Vol (3m):5,571,270
Market Cap:91.91M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
XOMAUp 0.84%91.91M
NVSDown 0.76%250.14B
REGNUp 4.81%61.14B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.64
Quarterly EPS Est (Jun-15) :-0.18
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-0.06

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback